PlainRecalls
FDA Drug Low Class III Terminated

Divalproex Sodium Delayed-Release Tablets, USP, 500 mg Valproic Acid Activity, 100-count tablets per bottle, Rx only, Manufactured by Upsher-Smith Laboratories, Inc., Minneapolis, MN 55447, NDC 0245-0182-11.

Reported: January 23, 2013 Initiated: December 10, 2012 #D-127-2013

Product Description

Divalproex Sodium Delayed-Release Tablets, USP, 500 mg Valproic Acid Activity, 100-count tablets per bottle, Rx only, Manufactured by Upsher-Smith Laboratories, Inc., Minneapolis, MN 55447, NDC 0245-0182-11.

Reason for Recall

Labeling: Label Error On Declared Strength; Some bottles of product were missing the color-coded strength on the primary display panel of the label.

Details

Units Affected
11,316 bottles
Distribution
Nationwide and Puerto Rico
Location
Maple Grove, MN

Frequently Asked Questions

What product was recalled?
Divalproex Sodium Delayed-Release Tablets, USP, 500 mg Valproic Acid Activity, 100-count tablets per bottle, Rx only, Manufactured by Upsher-Smith Laboratories, Inc., Minneapolis, MN 55447, NDC 0245-0182-11.. Recalled by Upsher Smith Laboratories, Inc.. Units affected: 11,316 bottles.
Why was this product recalled?
Labeling: Label Error On Declared Strength; Some bottles of product were missing the color-coded strength on the primary display panel of the label.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 23, 2013. Severity: Low. Recall number: D-127-2013.